VANCOUVER, BC--(MARKET WIRE)--Aug 27, 2007 -- Upstream Biosciences Inc. (OTC BB:UPBS.OB - News) today announced it has completed the acquisition of Pacific Pharma Technologies Inc., an early stage biopharmaceutical company with a proprietary technology platform that combines artificial intelligence, advanced computational methods and chemical diversity techniques to discover new drugs. This technology has already generated novel compounds that in laboratory studies demonstrate both human and veterinary potential against major tropical parasitic diseases.
